The Oligonucleotide Synthesis, Modification And Purification Services Market Is Projected To Grow At An Annualized Rate Of ~10%, Till 2030


The oligonucleotide synthesis, modification and purification services market is projected to grow at an annualized rate of ~10%, till 2030

Roots Analysis has done a detailed study on “Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030.”” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.


To order this 300+ page report, which features 140+ figures and 190+ tables, please visit this -


Key Market Insights

  • More than 80 companies currently claim to offer manufacturing related services, at different scales of operations, for a variety of oligonucleotide-based products
  • A wide range of services related to the synthesis, modification and purification of oligonucleotides, are currently offered within a fragmented service provider landscape that is mostly concentrated in the developed geographies
  • In order to cater to the growing needs of clients / sponsors, companies have established presence across different regions; the US and some European nations have emerged as current hubs for oligonucleotide production
  • Players involved in this domain are steadily expanding their capabilities in order to enhance their respective service portfolios and thereby, achieve an edge over competing firms
  • Service providers are actively investing in expansion projects to upgrade existing capabilities and capacity; several partnerships, mostly focused on offering manufacturing and supply services, have been forged
  • Over the past few years, more than 270 trials of oligonucleotide-based interventions, across various phases of development and to treat a diverse range of diseases, have been registered across different centers worldwide
  • Most of the global, annual oligonucleotide manufacturing capacity belongs to established service providers, accounting for over 80% of available capacity across various geographies
  • The demand for manufacturing of oligonucleotide-based products is expected to increase in the coming years; we believe that the stakeholders may have to expand their respective capacities to ensure consistent supply
  • We expect oligonucleotide-based drug developers to continue to outsource their manufacturing operations in the short to mid-term; service-based revenues are estimated to grow at an annualized rate of more than 10%
  • In the long-term, the projected opportunity is anticipated to be well distributed across various therapeutic areas, scales of operation and across companies of different sizes


For more information, please visit


Table of Contents



1.1.       Scope of the Report

1.2.       Research Methodology

1.3.       Chapter Outlines




3.1.       Context and Background

3.2.       Overview of Oligonucleotide-based Products

3.3.       Types of Oligonucleotides

3.3.1.    Antisense Oligonucleotides

3.3.2.    Aptamers

3.3.3.    miRNA

3.3.4.    shRNA

3.3.5.    siRNA

3.3.6.    Other Oligonucleotides

Gaurav Chaudhary

Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
+1 (415) 800 3415
+44 (122) 391 1091


Keywords: roots analysis,research,pharma,biotech,analysis,market research,industry reports,business report,global


Other related blogs

The customers who need to purchase the compartments

By : JK Rowling CBD Gummies

  JK Rowling CBD Gummies The customers who need to purchase the compartments of JK Rowling CBD..

The customers who need to purchase the compartments

By : JK Rowling CBD Gummies

  JK Rowling CBD Gummies The customers who need to purchase the compartments of JK Rowling CBD..

How To Buy An MTP Abortion Pill Kit Online?

By : Privacypillrx

Medication abortion is the process of terminating a pregnancy in the early stage with help of aborti..

The RNAi therapeutics market is anticipated to grow at an annualized rate of more than 45%, till 2030, claims Roots Analysis

By : Roots Analysis

The recent approval of first RNAi therapeutic, ONPATTROTM, has caused a surge in interest of the ind..